NCT06786364 Types of Photoplethysmographic Waves in Adult Patients with Septic Shock
| NCT ID | NCT06786364 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital General de México Dr. Eduardo Liceaga |
| Condition | Shock Septic |
| Study Type | OBSERVATIONAL |
| Enrollment | 116 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 116 participants in total. It began in 2024-11-01 with a primary completion date of 2025-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to identify the types of Photoplethysmographic waves present in adults with septic shock and determine whether these waves correlate with other variables of tissue hypoperfusion such as capillary refil, serum lactate and mottling score.
Eligibility Criteria
Inclusion Criteria: * Adult patients of 18 years of age and above dignossed with septic shock according to the definition stated in Sepsis 3.0 * Patients with axillary temperature above 36°C * Patients and/or family that agree to participate in such study and sign the informed consentment * Patients that tolerate supine position Exclusion Criteria: * Patients with Cardiogenic shock, hipovolemic, obstructive and distributive (neurogenic, anafilactic) shock the exception being septic shock * Patients with history of any type of cardiac arrhythmia * Patients with history of chronic hepatic disease * Patients with limited or diffuse systemic sclerosis * Patients that have scarring, nail polish or thickened nails that may impede the proper placement and accurate measurement of photoplethysmography with the pulse oximeter * Patients with history of heart insufficiency P- atients with septic shock that already have vasopressor aggents
Contact & Investigator
Juan Fernando Bautista Garcia, MD
PRINCIPAL INVESTIGATOR
Hospital General de México Dr. Eduardo Liceaga
Frequently Asked Questions
Who can join the NCT06786364 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Shock Septic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06786364 currently recruiting?
Yes, NCT06786364 is actively recruiting participants. Contact the research team at jbtagarcia@gmail.com for enrollment information.
Where is the NCT06786364 trial being conducted?
This trial is being conducted at Mexico City, Mexico.
Who is sponsoring the NCT06786364 clinical trial?
NCT06786364 is sponsored by Hospital General de México Dr. Eduardo Liceaga. The principal investigator is Juan Fernando Bautista Garcia, MD at Hospital General de México Dr. Eduardo Liceaga. The trial plans to enroll 116 participants.